To compare the effect of Phalatrikadi Kwath and Vrinda Triphaladi Kwath in obesity

A comparative study to evaluate the efficacy of Phalatrikadi Kwatha and Vrinda-Triphaladi Kwatha in Sthaulya (Obesity).

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/07/015075

Enrollment

Registered

2018-07-26

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E669- Obesity, unspecified Health Condition 2: E669- Obesity, unspecified Health Condition 3: null- Patients of either sex between 21 to 51 yr with BMI ranging from 25.0 to 35 Kg/m2

Interventions

Intervention1: Phalatrikadi Kwatha: 20 patients will be given Phalatrikadi kwatha in dose of 40 ml after mixing 12 gm of haridra kalka and 12 ml of honey in it twice in a day (empty stomach in morni

Eligibility

Inclusion criteria

Inclusion criteria: BMI ranging from 25.0 to 35 Kg/m2 Patients willing to participate and provide signed informed consent

Exclusion criteria

Exclusion criteria: Patients with Hypothyroidism Patients suffering from drug induced Obesity Patients with Diabetes Patients with severe Hypertension Patients with Renal Hepatic and Cardiac involvement Pregnant and Lactating women Patients having Gastro intestinal discomfort Patients who are not willing to participate with the study 9.Any other condition which may jeopardize the study.

Design outcomes

Primary

Measure	Time frame
Reduction in Weight Reduction in BMI Reduction in Waist circumference Reduction in Hip circumference Reduction in Waist â?? Hip Ratio Reduction in Serum VLDL Reduction in Serum LDL Reduction in Serum Triglycerides Reduction in Serum Total Cholesterol and an increase in Serum HDL Reduction in percentage relief in subjective criteria of SthaulyaTimepoint: Weight BMI Waist circumference Hip circumference Waist â?? Hip Ratio subjective criteria of Sthaulya on 0 day 21st day and 35th day Serum VLDL Serum LDL Serum Triglycerides Serum Total Cholesterol Serum HDL on 0 day and 21st day	—

Measure

Time frame

Reduction in Weight Reduction in BMI Reduction in Waist circumference Reduction in Hip circumference Reduction in Waist â?? Hip Ratio Reduction in Serum VLDL Reduction in Serum LDL Reduction in Serum Triglycerides Reduction in Serum Total Cholesterol and an increase in Serum HDL Reduction in percentage relief in subjective criteria of SthaulyaTimepoint: Weight BMI Waist circumference Hip circumference Waist â?? Hip Ratio subjective criteria of Sthaulya on 0 day 21st day and 35th day Serum VLDL Serum LDL Serum Triglycerides Serum Total Cholesterol Serum HDL on 0 day and 21st day

—

Secondary

Measure	Time frame
Assessment of reduction in the level of abdominal discomfort pain and Frequency of defecation during use of trial medicinesTimepoint: level of abdominal discomfort pain and Frequency of defecation on 0 day 7th day 14th day and 21st day	—

Countries

India

Contacts

Public ContactDr Parul Singh

Chaudhary Brahm Prakash Ayurved Charak Sansthan

naimishraj@yahoo.com9560659728

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026